• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses

tetano

Editor, Senior Moderator
Curr Opin Virol. 2014 Apr 2;6C:34-39. doi: 10.1016/j.coviro.2014.02.008. [Epub ahead of print]
Production of live attenuated influenza vaccines against seasonal and potential pandemic influenza viruses.
Jin H1, Chen Z2.
Author information
Abstract

Vaccination remains the most effective means to prevent morbidity and mortality caused by influenza epidemics and pandemics. Live attenuated influenza vaccine (LAIV) has been proven to be effective in preventing influenza with broad cross reactivity to drifted strains. Owing to the sophisticated nature of the influenza vaccine production process, the time needed to develop high yield LAIV strains for vaccine production and product release remains a constant challenge. This review summarizes LAIV production process with highlights on the experiences gained during the past decade generating seasonal and pandemic LAIV seeds by reverse genetics strategy.

Copyright ? 2014. Published by Elsevier B.V.

PMID:
24705137
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/24705137
 
Back
Top Bottom